60 related articles for article (PubMed ID: 24189098)
1. Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma.
Soini Y; Eskelinen M; Juvonen P; Kärjä V; Haapasaari KM; Saarela A; Karihtala P
Pathol Res Pract; 2014 Jan; 210(1):35-9. PubMed ID: 24189098
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.
Merikallio H; Pääkkö P; Kinnula VL; Harju T; Soini Y
Hum Pathol; 2012 Apr; 43(4):577-84. PubMed ID: 21943684
[TBL] [Abstract][Full Text] [Related]
3. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
[TBL] [Abstract][Full Text] [Related]
4. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
Isohookana J; Haapasaari KM; Soini Y; Karihtala P
Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.
Hartikainen JM; Tengström M; Kosma VM; Kinnula VL; Mannermaa A; Soini Y
Cancer Res; 2012 Nov; 72(21):5537-46. PubMed ID: 22964583
[TBL] [Abstract][Full Text] [Related]
7. DJ-1 Protects Breast Cancer Cells Against 2'-Benzoyloxycinnamaldehyde-induced Oxidative Stress Independent of Nrf2.
Ismail IA; Abdel Shakor AB; Hong SH
J Cell Physiol; 2015 Sep; 230(9):2262-9. PubMed ID: 25677538
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
van Horssen J; Drexhage JA; Flor T; Gerritsen W; van der Valk P; de Vries HE
Free Radic Biol Med; 2010 Nov; 49(8):1283-9. PubMed ID: 20673799
[TBL] [Abstract][Full Text] [Related]
9. SETD6 is a negative regulator of oxidative stress response.
Chen A; Feldman M; Vershinin Z; Levy D
Biochim Biophys Acta; 2016 Feb; 1859(2):420-7. PubMed ID: 26780326
[TBL] [Abstract][Full Text] [Related]
10. The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma.
Hollander LL; Guo X; Salem RR; Cha CH
J Surg Res; 2015 Aug; 197(2):219-24. PubMed ID: 25982376
[TBL] [Abstract][Full Text] [Related]
11. DJ-1: a novel independent prognostic marker for survival in glottic squamous cell carcinoma.
Zhu XL; Wang ZF; Lei WB; Zhuang HW; Jiang HY; Wen WP
Cancer Sci; 2010 May; 101(5):1320-5. PubMed ID: 20345476
[TBL] [Abstract][Full Text] [Related]
12. Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.
Mazur W; Lindholm P; Vuorinen K; Myllärniemi M; Salmenkivi K; Kinnula VL
APMIS; 2010 Sep; 118(9):703-12. PubMed ID: 20718723
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival.
Wang J; Zhang M; Zhang L; Cai H; Zhou S; Zhang J; Wang Y
J Surg Res; 2010 Nov; 164(1):e99-105. PubMed ID: 20828733
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma.
Cui Y; Tian M; Zong M; Teng M; Chen Y; Lu J; Jiang J; Liu X; Han J
Pancreatology; 2009; 9(1-2):89-98. PubMed ID: 19077459
[TBL] [Abstract][Full Text] [Related]
15. Nrf2-peroxiredoxin I axis in polymorphous adenocarcinoma is associated with low matrix metalloproteinase 2 level.
Brod JM; Demasi APD; Montalli VA; Teixeira LN; Furuse C; Aguiar MC; Soares AB; Sperandio M; Araujo VC
Virchows Arch; 2017 Dec; 471(6):793-798. PubMed ID: 28849259
[TBL] [Abstract][Full Text] [Related]
16. DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients.
Kawate T; Iwaya K; Kikuchi R; Kaise H; Oda M; Sato E; Hiroi S; Matsubara O; Kohno N
Breast Cancer Res Treat; 2013 May; 139(1):51-9. PubMed ID: 23592371
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer.
Kawasaki Y; Ishigami S; Arigami T; Uenosono Y; Yanagita S; Uchikado Y; Kita Y; Nishizono Y; Okumura H; Nakajo A; Kijima Y; Maemura K; Natsugoe S
BMC Cancer; 2015 Jan; 15():5. PubMed ID: 25588809
[TBL] [Abstract][Full Text] [Related]
18. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.
Clements CM; McNally RS; Conti BJ; Mak TW; Ting JP
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15091-6. PubMed ID: 17015834
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
[TBL] [Abstract][Full Text] [Related]
20. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
